Gilead recalls vials of its Remdesivir covid drug in U.S. due to glass contamination
American biopharmaceutical company Gilead Sciences Inc. has issued a nationwide recall of two lots of its coronavirus treatment drug Remdesivir due to the "presence of glass particulates," the company said Friday.
Remdesivir, known also by its brand name "Veklury," is normally used for adults and children over 12 requiring hospitalization for covid-19, and is normally given in a vein by intravenous (IV) infusion one time each day for up to 10 days.
"Gilead Sciences Inc. received a customer complaint, confirmed by the firm's investigation, of the presence of glass particulates," it said in a statement.
"An injectable product that contains glass particulates may result in local irritation or swelling in response to the foreign material. If the glass particulate reaches the blood vessels it can travel to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death," it added.
https://finance.yahoo.com/gilead-recalls-vials-remdesivir-covid-122120730.html
